Commonly made of 316L stainless steel and nitinol, metallic intravascular stents are medical devices used to scaffold a biological lumen, most often diseased arteries. While stenting procedures reduce the risk of restenosis, they do not eliminate it completely. Furthermore, other common complications observed are thrombosis, inflammation and corrosion of the stents. The corrosion of the device is induced by blood flow which provokes a degradation of its mechanical properties and leads to a high risk of release of potentially toxic metallic compounds, such as nickel-based oxides and metal ions. To lower these clinical complication rates and to prevent the corrosion of the metallic stent structure, coated stents have been developed during the last decade. Indeed, the coating is expected to improve the surface biocompatibility and corrosion resistance without compromising the stainless steel mechanical properties required for the stent implantation. The Food and Drug Administration (FDA) has already provided guidance on a series of non-clinical test protocols, methods and reports to evaluate the safety and effectiveness of intravascular stents. Properties such as the stability, durability, and adhesion of a stent coating, prior and after deployment, must be clearly assessed to demonstrate its efficiency. This study wants to evaluate the effectiveness against general and local corrosion of an ultra-thin fluorocarbon film deposited by plasma on pre-treated stainless steel. Cyclic polarization tests were used to measure the coating capacity to protect the substrate from localized corrosion and Tafel plot corrosion measurements were used to evaluate the general corrosion behaviour of uncoated and coated, flat and deformed samples.